Umbilical Vessel Catheters Market Overview
Umbilical catheters are thin flexible tubes incorporated in the base of artery or vein of a baby’s umbilical cord. Umbilical catheters are used for the treatment of premature infants. Umbilical catheters go about as an open section which enables specialists to carry out the treatment effortlessly. These catheters are employed to deliver special nutrition, drugs, and liquids to a newborn. Umbilical catheters are fundamentally of two types: umbilical artery catheter and umbilical venous catheter. Umbilical artery catheter is embedded into the artery of the umbilical cord to remove blood for blood test and to check blood pressure. This catheter requires less needle sticks to extract blood sample for blood test. Umbilical venous catheter is embedded into the vein of umbilical cord to provide liquid and drug to the newborn. These catheters need substantial slit to deliver pharmaceuticals and liquid to the newborn. According to FDA (U.S. Food and Drug Delivery Administration) rules, umbilical catheter can be used for seven days or less. If further treatment is required, specialists can insert the peripheral catheter in the leg or arm.
Market Size & Forecast
According to WHO (World Health Organization), 15 million babies are born prematurely every year and this number tends to increase over the forecast period. The umbilical vessel catheters market is thus estimated to expand at a robust CAGR over the forecast period.
The umbilical vessel market is sectioned on the basis of product type and end user. Based on the end user both umbilical venous catheter and umbilical artery catheter are estimated to gain nearly equal market share. Based on end user umbilical vessel catheters market is categorized as hospitals and neonatal care center. Among all end-users, hospital is estimated to advance maximum market share over the forecast period. The umbilical vessel catheter market is estimated to demonstrate exponential progress owing to increase in healthcare expenses for neonatal nurture. WHO stated that three-quarter of prematurely born babies has been saved in 2016 by exercising cost effectual mediation.
Get more information on this report: Download Sample PDF
On the basis of regional platform, global insulin managements market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.
North America is the second most profitable region for umbilical vessel catheters market due to increase in number of neonatal care centers and favorable reimbursements setup. After North America, this market is then followed by Europe.
The Asia-Pacific region is expected profit maximum market shares owing to high number of premature births in India and China. Improvement in health care infrastructure, increase in the number of premature babies in developing countries and surge in medical tourism across several developing economies have added to the growth of the market in Asia Pacific.
The minimal profiting market for umbilical vessel catheter is Middle East & Africa region because of lack of awareness among the people and less healthcare infrastructures.
Market Segmentation
Our-in depth analysis of the Global Insulin managements market includes the following segments:
By Product Type
- Umbilical artery catheters (UAC)
- Umbilical vein catheters (UVC)
By End-User
- Hospitals
- Neonatal Care Centers
By Region
Global Insulin managements Market is further classified on the basis of region as follows:
- North America (United States, Canada), Market size, Y-O-Y growth Market size, Y-O-Y growth & Opportunity Analysis, Future forecast & Opportunity Analysis
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
- Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Norway, Denmark, Sweden, Finland), Poland, Russia, Rest of Europe), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
- Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
Growth Drivers & Challenges
The increase in the number of premature deliveries all over the world and increase in the number of neonatal care center are the primary elements propelling the progress of umbilical vessel catheter market. The umbilical cord has no pain receptor; therefore incorporation of umbilical vessel catheter is not painful for the newborn. Moreover, umbilical vessel catheter requires fewer needle sticks during the treatment. These factors will increase the demand of umbilical vessel catheter for the treatment of premature neonatal. The increased focus of medical devices manufacturers for the R&D on the neonatal products will enhance the progress of this market. Constant blood pressure observation and sample collection of blood gases can be done effortlessly by exercising the umbilical vessel catheter which will again increase the demand for this market.
The hazard of infection and blood clotting during the treatment by using umbilical vessel catheter will slow down the growth of this market. Furthermore, cost constraints of product and deficiency of trained professionals to operate umbilical vessel catheters will hinder the growth of this market over the forecast period.
Top Featured Companies Dominating The Market
- Medtronic PLC
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Vygon SA
- Neotech Products
- Anthelio Healthcare Solutions Inc.
- SURU International Pvt. Ltd.
- Utah Medical Products, Inc.
- Centurion Medical Products.
- Hummingbird Medical.
